• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    Novartis Releases Fourth Quarter and Full Year Financials

    Gabrielle Lakusta
    Jan. 24, 2018 08:46AM PST
    Pharmaceutical Investing

    Novartis (NYSE:NVS) delivered good operational performance and landmark innovation in 2017, entering our next growth phase. As quoted in the release: Vas Narasimhan, designated CEO from February 1, commented: “I want to thank Joe and the Board for their leadership and guidance as I transition to my new role. As CEO my priorities will be …

    Novartis (NYSE:NVS) delivered good operational performance and landmark innovation in 2017, entering our next growth phase.

    As quoted in the release:

    Vas Narasimhan, designated CEO from February 1, commented:

    “I want to thank Joe and the Board for their leadership and guidance as I transition to my new role. As CEO my priorities will be driving our next growth phase by strengthening operational execution, delivering more breakthrough innovation, pivoting to become a data centric, digitally enabled organization, building trust and reputation and transforming our culture. I feel privileged to lead Novartis at this exciting time.”

    Click here for the full release.

    pharmaceutical investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Pharmaceutical pills with dollar signs on them.

    Top 10 Pharma Companies by Revenue

    Various colorful pills and tablets scattered from a brown bottle on a blue background.

    Pharma Market Forecast: Top Trends for Pharma in 2026

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    InMed Pharmaceuticals

    InMed Pharmaceuticals (INM)
    INM

    Cardiol Therapeutics

    Cardiol Therapeutics (CRDL:CC)
    CRDL:CC
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES